C12Y406/01001 - CPC Classification Index

#1

20260043031

2026-02-12

COMPOSITIONS AND METHODS FOR INHIBITING ADENYLATE CYCLASE 9 (AC9)

#2

20230165950

2023-06-01

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

#3

20230042456

2023-02-09

INCREASING SPACE-TIME-YIELD, CARBON-CONVERSION-EFFICIENCY AND CARBON SUBSTRATE FLEXIBILITY IN THE PRODUCTION OF FINE CHEMICALS

#4

20220356460

2022-11-10

PHOTOACTIVATED ADENYLYL CYCLASE

#5

20220064685

2022-03-03

BIOSYNTHETIC METHODS AND SYSTEMS FOR PRODUCING MONOSACCHARIDES

#6

20210220462

2021-07-22

IMMUNOGENIC PROTEINS AND COMPOSITIONS

#7

20200246313

2020-08-06

METHODS FOR DIAGNOSING AND TREATING PROSTATE CANCER

#8

20190307875

2019-10-10

IMMUNOGENIC COMPOSITION COMPRISING CYAA-DERIVED POLYPEPTIDE PROMOTING A TH1/TH17-ORIENTED IMMUNE RESPONSE

#9

20190264189

2019-08-29

Compositions and methods for the treatment or prevention of heart failure

#10

20190017041

2019-01-17

LEUCINE BETA ROLL DOMAINS AND USES THEREOF

#11

20180327721

2018-11-15

Host cells with artificial endosymbionts

#12

20180318387

2018-11-08

METHODS FOR DIAGNOSING AND TREATING SYSTEMIC LUPUS ERYTHEMATOSUS

#13

20180256699

2018-09-13

BORDETELLA ADENYLATE CYCLASE TOXIN VACCINES AND NEUTRALIZING ANTIBODIES

#14

20180208919

2018-07-26

Monomeric and functional adenylate cyclase CyaA toxin

#15

20170362310

2017-12-21

VHH based binding antibodies for anthrax and botulinum toxins and methods of making and using therefor

#16

20170340702

2017-11-30

Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody

#17

20170247663

2017-08-31

Host cells with artificial endosymbionts

#18

20170204402

2017-07-20

In vivo detection of proteins interaction based on adenylate cyclase hybrid system

#19

20170182083

2017-06-29

Use of 15 male fertility related proteins or combination thereof

#20

20170096458

2017-04-06

CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses

#21

20170081652

2017-03-23

Near-infrared light-activated proteins

#22

20170000882

2017-01-05

Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity

#23

20160376561

2016-12-29

Host cells with artificial endosymbionts

#24

20160375119

2016-12-29

Vectors for molecule delivery to CD11b expressing cells

#25

20160152966

2016-06-02

Leucine beta roll domains and uses thereof

#26

20160138066

2016-05-19

Methods for the expression of peptides and proteins

#27

20160101164

2016-04-14

Cycle adenosine monophosphate-incompetent adenylyl cyclase and compositions and methods for treating heart failure and increasing cardiac function

#28

20160083714

2016-03-24

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#29

20160015806

2016-01-21

Genetically detoxified pertussis vaccine that maintains intrinsic adjuvant activity

#30

20150291665

2015-10-15

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

#31

20150250867

2015-09-10

HPV/CyaA-based chimeric proteins and their uses in the induction of immune responses against HPV infection and HPV-induced disorders

#32

20150240313

2015-08-27

Use of ADCY3 for diagnosis and treatment of gastric cancer

#33

20150184143

2015-07-02

CyaA-based chimeric proteins comprising a heterologous polypeptide and their uses in the induction of immune responses

#34

20150013024

2015-01-08

NEAR-INFRARED LIGHT-ACTIVATED PROTEINS

#35

20140096439

2014-04-10

Butanol tolerance in microorganisms

#36

20130237612

2013-09-12

Leucine beta roll domains and uses thereof

#37

20130183758

2013-07-18

Host cells with artificial endosymbionts

#38

20130030041

2013-01-31

Near-infrared light-activated proteins

#39

20120214206

2012-08-23

Vectors for molecule delivery to CD11b expressing cells

#40

20120071393

2012-03-22

Mutant CyaA polypeptides and polypeptide derivatives suitable for the delivery of immunogenic molecules into a cell

#41

20100310594

2010-12-09

RECOMBINANT ADENYLATE CYCLASE TOXIN OF BORDETELLA INDUCES T CELL RESPONSES AGAINST TUMORAL ANTIGENS

#42

20100150999

2010-06-17

THERAPY OF CANCER BASED ON TARGETING ADAPTIVE, INNATE AND/OR REGULATORY COMPONENT OF THE IMMUNE RESPONSE

#43

20090149376

2009-06-11

Pharmaceutical and therapeutic applications relating to a type 9 adenylyl cyclase Polymorphism in asthma and reversible bronchial obstruction

#44

20090117143

2009-05-07

Recombinant adenylate cyclase toxin of induces T cell responses against tumoral antigens

#45

20080152665

2008-06-26

Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response

#46

20070026022

2007-02-01

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

#47

20060159697

2006-07-20

Modified bordetella adenylate cyclase comprising or lacking CD11b/CD18 interaction domain and uses thereof

#48

20050271679

2005-12-08

Recombinant adenylate cyclase toxin of Bordetella induces T cell responses against tumoral antigens

#49

20050238637

2005-10-27

Vectors for molecule delivery to CD11b expressing cells

#50

20050124791

2005-06-09

Ion channel

#51

20050048479

2005-03-03

Adenylyl and guanylyl cyclases